Recall Register

Drug recall: Doxercalciferol Capsules 0.5mcg, 50 count bottles, Rx, only, Manufactured by Cipla Limited Kurkumbh, Maharashtra…

Class III FDA enforcement event 76822. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.

Class III, in the words of FDA

a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences

West-Ward Columbus, Inc. started this drug recall on 4 Apr 2017. The firm address in the FDA record is in Columbus, OH. FDA put the recall in Class III. FDA event 76822 has 1 product record. The first FDA enforcement report date is 19 Apr 2017. The record gives the status Terminated, with the termination date 4 Sep 2018. 93 of the 343 drug events that started in 2017 have more product records. The median drug event of 2017 has 1 product record. The openFDA file has 343 drug events that started in 2017 and 288 that started in 2016.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

The recalled product was distributed to the following state: OH. There are no Canada accounts for this recall. There are no Mexico accounts for this recall. There are no government accounts for this…

Recalling firm

West-Ward Columbus, Inc., Columbus, OH.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 76822: product records
Recall numberProductQuantityClassStatusReport date
D-0651-2017Doxercalciferol Capsules 0.5mcg, 50 count bottles, Rx, only, Manufactured by Cipla Limited Kurkumbh, Maharashtra, India, Manufactured for West-Ward, Pharmaceuticals, Corp., Eatontown, NJ -- NDC 0054-0338-19100 bottlesClass IIITerminated19 Apr 2017

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class III: The lowest of the three FDA recall classes.

The event in context

Drug events that started in 2017
343
Share of these events in Class III
30%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
9

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 76822. https://recallregister.com/fda/iii/76822/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: The recalled product was distributed to the following state: OH. There are no Canada accounts for this recall. There are no Mexico accounts for this recall. There are no government accounts for this…
What quantity of product is in FDA event 76822?
The FDA record gives this quantity: 100 bottles
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2017 have the same class?
30% of the 343 drug events that started in 2017 are in Class III.